Who Paid My Doc Search
Menu
Organisation paid for research Program year 2025 Source: CMS Open Payments

Moyes Eye Center

Neither a doctor nor a teaching hospital

Research payments

$1,359,422

1,550 payments

Through program year 2025, Moyes Eye Center is reported as receiving $1,359,422 in research payments, across 1,550 payments.

By program year

7 rows
Year Kind Amount Payments
2025 Research $187,493 137
2024 Research $229,051 217
2023 Research $17,095 12
2022 Research $210,229 398
2021 Research $550,254 703
2020 Research $117,434 71
2019 Research $47,868 12

Breakdown

Who paid Research payments · program years 2019–2025
  1. Alcon Research LLC $1,095,920 1,406 payments
  2. Oyster Point Pharma, Inc. $88,321 11 payments
  3. Glaukos Corporation $70,932 26 payments
  4. Dompe US, Inc. $44,013 4 payments
  5. Novartis Pharmaceuticals Corporation $32,754 2 payments
  6. Argenx US, Inc. $25,990 97 payments
  7. Allergan Inc. $1,492 4 payments
Studies the money was for Research payments · program years 2019–2025
  1. Pivotal Trial of WaveLight EX500 Excimer Laser System for the Correction of Myopia with and without Astigmatism Using InnovEyes in Conjunction with InnovEyes sightmap $507,412 621 payments
  2. Contralateral Study of Clareon PanOptix Pro vs. Clareon PanOptix $256,602 232 payments
  3. Post Approval Study of the AcrySof IQ ReSTOR Toric IOL $225,429 487 payments
  4. Safety and Efficacy of 0.75% Phentolamine Ophthalmic Solution in Subjects With Post-refractive Surgery Visual Disturbances (LYNX-2) $77,986 8 payments
  5. A 4 Weeks, Phase II, Multicenter, Randomized, Double-masked, Vehicle-controlled, Parallel Group Study With 12 Weeks of Follow-up to Evaluate Safety and Efficacy of rhNGF Eye Drops Solution vs Vehicle in Moderate to Severe Dry Eye $44,013 4 payments
  6. Prospective, Randomized Phase 3 Study Comparing Two Models of a Travoprost Intraocular Implant to Timolol Maleate Ophthalmic Solution, USP, 0.5% $40,054 11 payments
  7. Clinical Investigation of the WaveLight EX500 Excimer Laser for Hyperopic LASIK $36,851 38 payments
  8. A Randomized, Double-Masked, Multicenter Study to Evaluate the Safety and Efficacy of Ecf843 VS Vehicle in Subjects With Dry Eye Disease $32,754 2 payments
  9. Prospective, Randomized Phase 3 Study Comparing Two Models of a Travoprost Intraocular Implant to Timolol Maleate Ophthalmic Solution, USP, 0.5 $30,675 14 payments
  10. 12 months follow-up observational extension of ILQ137-C002 study (Clareon PanOptix vs Clareon PanOptix IOLs) $27,750 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record